Clinical characteristics and outcomes in hypertensive patients of Hispanic descent

Preventive Cardiology
Juan M ArandaJuan M Aranda

Abstract

In the United States, patients of Hispanic descent have higher rates of hypertension-related morbidity and mortality than patients from other ethnic groups even though the prevalence of hypertension among Hispanics is lower. This discrepancy likely reflects lower rates of hypertension awareness and control among Hispanics as well as a higher prevalence of diabetes mellitus and other cardiovascular risk factors in this population. Although available data suggest that patients of Hispanic descent who receive antihypertensive therapy experience responses and treatment benefits similar to those achieved by other ethnic groups, clinical trials of antihypertensive therapy have typically enrolled only small numbers of Hispanic patients. Agents targeting the renin-angiotensin system, namely angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers, may be particularly useful in the Hispanic population given the ability of these drugs to protect against hypertension-related and diabetes-related end-organ damage independent of their blood pressure-lowering effects.

References

May 1, 1992·Hypertension·M Epstein, J R Sowers
Aug 15, 1996·Annals of Internal Medicine·E Grossman, F H Messerli
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Oct 26, 2001·JAMA : the Journal of the American Medical Association·S YusufUNKNOWN HOPE Study Investigators
Jan 16, 2002·JAMA : the Journal of the American Medical Association·Earl S FordWilliam H Dietz
May 9, 2002·Archives of Internal Medicine·Jiang HePaul K Whelton
Aug 27, 2002·Journal of Hypertension·Lars H LindholmUNKNOWN LIFE study group
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Apr 3, 2003·The Journal of Clinical Hypertension·Sean O HendersonBrian E Henderson
Jul 10, 2003·JAMA : the Journal of the American Medical Association·Ihab Hajjar, Theodore A Kotchen
Oct 9, 2003·JAMA : the Journal of the American Medical Association·K M Venkat NarayanDavid F Williamson
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Mar 3, 2004·Pediatrics·Jonathan M SorofRonald J Portman
Apr 13, 2004·Journal of Hypertension·Anders NiklasonUNKNOWN Captopril Prevention Project Study Group
Feb 15, 2005·Clinical Cornerstone·Juan M Aranda, Raul Vazquez
Feb 15, 2005·Clinical Cornerstone·Maria L Soto-GreeneRobert C Like
Feb 15, 2005·Clinical Cornerstone·Eliseo J Perez-Stable, Rene Salazar
Feb 18, 2005·Journal of Hypertension·Karin A M Jandeleit-DahmMark E Cooper
May 12, 2006·The Journal of Clinical Hypertension·Keith C Ferdinand
May 23, 2006·Hypertension·Paul M RidkerUNKNOWN Val-MARC Investigators
Jun 24, 2006·Journal of Hypertension·Sverre E KjeldsenUNKNOWN VALUE Trial Investigators
Jul 11, 2006·The American Journal of Cardiology·Nathan D WongG Rhys Williams
May 9, 2007·The Journal of Clinical Hypertension·Thomas GilesFeride Frech-Tamas
Jul 31, 2007·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·L Leanne Lai

❮ Previous
Next ❯

Citations

Nov 10, 2013·American Journal of Health Promotion : AJHP·Angela HilmersKaren W Cullen
Aug 24, 2010·Annals of Epidemiology·Majd AlGhatrifKyriakos S Markides
May 27, 2016·Journal of Immigrant and Minority Health·Ruth M Masterson CreberSuzanne Bakken

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.